Diperiodatoargentate(III) (DPA)/silver(III) complex, [Ag(HIO6)2] 5-, in sulfuric acid medium has been used to determine hyoscine butylbromide (HBB) by flow injection (FI) coupled with chemiluminescence (CL) detector. A linear standard curve between the CL intensity and concentration range from 0.005 to 20 mg L -1 was obtained. The determination coefficient (R 2 ), limit of detection (3s × blank), relative standard deviation (RSD) for 0.5 mg L -1 HBB and analytical throughput were 0.9992 (n = 8), 5 × 10 -4 mg L -1 , 1.5% (n = 10) and 160 injections h -1 , respectively. The developed method was applied for the determination of HBB in pharmaceutical formulations with recoveries from 92 ± 4 to 108 ± 3%. For comparison, a spectrophotometric method was used and the results obtained by both methods were in good agreement at a 95% confidence level. The effect of key chemical and physical variables (reagent concentration, flow rate, sample volume, PMT voltage) and interfering species (pharmaceutical excipients and inorganic ions) on the determination of HBB was examined. The possible CL mechanism of HBB on silver(III) complex in sulfuric acid medium was also discussed in brief.
Introduction
Hyoscine butylbromide (HBB, C21H30BrNO4, Mw 440.4), a derivative of hyoscine/scopolamine (C17H21NO4, Mw 303.353) also known as scopolamine butylbromide or butylhyoscine, is one of the earliest alkaloids extracted and purified from dried Duboisia leaves belonging to the Solanaceae family. 1 HBB has been useful for the treatment of peptic ulcer, gastritis, and other gastrointestinal disorders. It is also found to relieve spasmodic conditions of the bile duct and treating dysmenorrhoea. 2, 3 The butylbromide component works effectively to avoid the progress of HBB across the blood-brain barrier, which decreases unnecessary central nervous system side effects related to hyoscine. 4 Several comprehensive reviews have been published employing HBB for treating cramping abdominal pain, 5 examining the drug in a number of clinical tests, 6 and assessing the efficacy of HBB and its use in biliary colic.
1 Figure 1 shows the chemical structure of HBB.
The literature reports several analytical techniques such as spectrophotometry, [7] [8] [9] [10] chromatography, [11] [12] [13] [14] [15] [16] [17] [18] electrochemical, [19] [20] [21] [22] capillary electrophoresis, 23, 24 and titrimetry, 25, 26 for HBB analysis in biological and pharmaceutical samples. These analytical methods are sensitive and have good precision, however, some of these methods are not commonly employed in routine laboratories owing to large reagent consumption, lengthy procedures and low sample throughputs.
The use of a CL detector coupled with the FI technique is attractive due to the high sensitivity, higher sample throughput, wide linear range, simple instrumentation and possibility of multiple applications in various fields of analytical chemistry. [27] [28] [29] Silver(III), copper(III) and nickel(IV) have been used as oxidizing agents in the CL reactions using polydentate ligands. 30 Transition metals at unstable high oxidation states including diperiodatoargentate(III) (DPA)/silver(III)/complex, [Ag (HIO6)2] 5-, is considered to be a strong oxidizing agent with the reduction potential of 1.74 V in alkaline medium. 31 DPA and monoperiodatoargentate (MPA, Ag(HIO6)(OH)(H2O)] 2-) are the active forms for complex formation and oxidation of other compounds. 32 MPA dissociates into orthoperiodic acid (H5IO6) and silver(III) cation in sulfuric acid (H2SO4) solution. The later liberates protons (H + ) and superoxide-anion radicals (O2 -• solution. A part of the superoxide-anion radicals may recombine to form energy rich molecular oxygen dimer, 33, 34 which gives luminescent light centered at 490 nm on decomposition. The energy can be transferred from the energy rich oxygen dimer to excite fluorophore due to intermolecular collision, which emits energy on de-excitation. The characteristic wavelength of the emitted CL light depends on the nature of the analyte. In the literature, different FI-CL methods have been reported using DPA as an oxidizing agent in aqueous H2SO4 medium for the determination of pharmaceutically and clinically important analytes such as lomefloxacin, enrofloxacin, pefloxacin, 35 norfloxacin, 36 enoxacin, 37 ofloxacin and levofloxacin, 38 indole-3-acetic acid, 39 hydrocortisone, 40 and cyromazine, 41 in pharmaceuticals, biological fluids, milk, soil and water samples.
This study describes a simple and sensitive analytical procedure employing the silver(III) complex for the CL analysis of HBB using the FI technique. It was found that the silver(III) complex in acidic condition gives a weak CL intensity and HBB could strongly enhance the CL intensity. This increase in CL intensity was used to determine HBB concentration from 0.005 to 20 mg L -1 with LOD (3s × blank) of 5 × 10 -4 mg L -1 and sampling rate of 160 h -1 . Results were satisfactory when commercially available pharmaceutical formulations containing HBB were analyzed.
Materials and Methods

Chemicals and standards
Chemicals were purchased from BDH Chemicals Ltd., Poole and Fisher Scientific Chemicals, UK and Merck, Darmstadt, Germany and deionized water (0.0167 μS cm -1 , Elga Purelab Option, Bucks, UK) was used throughout the experimental work. HBB reagent was obtained from Merck Pharmaceutical Co., Quetta, Pakistan. HBB tablets and injections containing 10 mg HBB Tablet -1 (Buscopan Plus Tablets, sample 1), and Buscopan 20 mg HBB mL -1 solution (sample 2), Merck (Pvt) Ltd., Karachi, and Spacure 10 mg HBB Tablet -1 (sample 3), and Spacure 20 mg HBB mL -1 solution (sample 4), SAFE Pharmaceutical (Pvt) Ltd., Karachi, were purchased and subjected to analytical procedures.
The silver(III)/DPA complex was prepared according to the previously reported procedure. 42 In brief, the mixture solution of silver nitrate (AgNO3, 1.36 g), potassium periodate (KIO4, 3.24 g), sodium persulfate (Na2S2O8, 3.0 g), and potassium hydroxide (KOH, 8.0 g) was prepared in 200 mL water and heated to boiling for about 40 min on a hotplate (Cenco Instrument MIJ N.V., Breda, the Netherlands) with constant stirring. The DPA complex obtained was dried and stored at room temperature and was found stable for several months. From the freshly prepared DPA stock solution, different working standard solutions were prepared in 0.01 mol L -1 sodium hydroxide (NaOH) solution when required. DPA complex gave two absorbance peaks at 253 and 362 nm and its concentration was determined at 362 nm using a spectrophotometer (UV-1700, Pharmaspec, Shimadzu, Kyoto, Japan), with molar absorptivity of (ε = 1.26 × 10 4 L mol -1 cm -1 ). 43 NaOH (1.0 mol L -1 ) was prepared weighing 10 g of pre-dried pellets in 250 mL of water.
H2SO4 solution (2.0 mol L -1 ) was prepared diluting 27.8 mL of the commercially available H2SO4 (18 mol L -1 ) in 250 mL water. HBB solution (0.1 g L -1 ) was prepared dissolving 0.1 g of compound in water and stored at 4 C. Stock solutions (0.1 g L -1 ) of some common pharmaceutical excipients such as starch, acacia, tartaric acid, silica, glucose, and sucrose, povidone and polyethylene glycol and inorganic ions such as sodium, potassium, calcium, magnesium, zinc, ammonium, sulfate, phosphate, nitrate and chloride were prepared from their respective salts in water.
Procedures for sample preparation
The contents of 4 tablets were thoroughly powdered and mixed from individual samples. A weighed quantity (10 mg powder, containing HBB and ingredients) of tablet powder was dissolved in 20 mL water, sonicated for 5 min and centrifuged at 5000 rpm to remove any insoluble matter. From this solution, appropriate aliquots were taken and diluted with water. The contents of ampoules were thoroughly mixed and a volume of 2 mL solution (40 mg as HBB) from individual samples was transferred into a 50-mL volumetric flask and diluted with water up to the mark. Working standard solutions were made from this stock solution in water.
Flow injection manifold and procedure
The FI-CL manifold used for the analysis of HBB is shown in Fig. 2 . Polytetrafluoroethylene tubes (PTFE, 0.8 mm i.d., Fisher Scientific, Loughborough, UK) were used for connecting all the FI components. A peristaltic pump (Ismatec, GlattbruggZurich, Switzerland) propelled all the solutions through the system at 3.5 mL min -1 . HBB standard solutions (180 μL) were injected through Rheodyne 5020 injection valve (Anachem, Luton, UK) into the deionized water stream, which was combined at a T-piece with H2SO4 solution (0.5 mol L -1 ). This stream was then combined at a second T-piece with the silver(III) complex solution (2.5 × 10 -4 mol L -1 in 0.01 mol L -1 NaOH) stream. The combined streams travelled 5 cm and were allowed to pass through the spiral glass flow cell (1.5 mm i.d., 18 mm dia), producing CL intensity. The flow cell was placed directly in front of an end window PMT (Electron Tubes, Ruislip, UK) connected with a PM20SN power supply (Electron Tubes) and operated at 1.250 kV. The CL signals were recorded on a chart recorder strip (BD40, Kipp & Zonen, Delft, Holland).
Accuracy of the method
For the determination of HBB, the proposed FI-CL method was compared with a spectrophotometric method. were added to each flask, respectively, shaken well and diluted up to 25 mL with water. These solutions were allowed to stand at 25 C for 15 min and the absorbance was monitored at 610 nm using a spectrophotometer equipped with 10 mm quartz cuvettes. Similarly, pharmaceutical formulations containing HBB were analyzed and the quantity of HBB was determined from the standard graph of concentration versus absorbance and the results were compared with the proposed FI-CL method.
Results and Discussion
Kinetic study Figure 3 shows the kinetic characteristics of silver(III) complex-HBB CL system in H2SO4 medium, in a static system. When HBB standard prepared in sulfuric acid solution was injected into the silver(III) complex prepared in sodium hydroxide solution, it produced a relatively strong CL signal that reached its maximum in 1 s. The CL intensity decreased to the baseline within 3.5 s, indicating that the CL system is suitable for the analysis of HBB in pharmaceutical samples.
Optimization of the CL reaction
The experimental variables studied were reagent concentration, flow rate, sample volume and photomultiplier tube voltage (Table 1 ) using a HBB standard (0.5 mg L -1 ) solution. All the results were the mean of triplicate measurements.
The influence of silver(III) over the range 1.0 × 10 -5 to 5.0 × 10 -4 mol L -1 was investigated on the CL emission and 2.5 × 10 -4 mol L -1 silver(III) complex concentration was found to be the optimum, and was thus used for further studies. The silver(III) complex solution was prepared in NaOH to obtain maximum CL efficiency. The effect of NaOH concentration on the CL emission was examined over the range 0.001 to 0.025 and 0.01 mol L -1 was found to be the optimum and employed subsequently. The effect of H2SO4 concentration on the CL emission was studied from 0.01 to 1.0 mol L -1 , and 0.5 mol L -1 was determined to be the optimum concentration and used in subsequent experiments.
The flow rates and sample volume are important key physical parameters that could affect the sensitivity of the CL system. Therefore, the influence of flow rate (range tested 0.5 -4.0 mL min -1 ) and sample volume (range tested 60 -400 μL) on the CL response was examined. Flow rate of 3.5 mL min -1 for all three streams and sample loop volume of 180 μL offered optimum CL intensities. Further increase in flow rate and sample volume had little or no effect on CL response. Therefore, a flow rate of 3.5 mL min -1 and a sample loop volume of 180 μL were selected for subsequent measurements. The influence of PMT voltage in the range from 0.850 to 1.300 kV was also investigated. A positive curve linear increase in CL intensity with increase in PMT voltage was observed. However, a PMT voltage of 1.250 kV was recommended due to suitable signalto-noise ratio.
Analytical performance
With the optimized flow system, a linear calibration curve in the range from 0.005 to 20 mg L -1 (R 2 = 0.9992, n = 8) was obtained with regression equation of y = 474.67x + 1.059 (y = CL intensity in mV and x = concentration of HBB in mg L -1 ). The limit of detection (LOD, 3s × blank) and limit of quantification (LOQ, 10s × blank) were 5 × 10 -4 and 1.7 × 10 -3 mg L -1 , respectively. The RSD for HBB standard solution of 0.5 mg L -1 was 1.5% (n = 10) and the injection throughput was 160 h -1
. Chart recorder traces of CL signals for a series of HBB 
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For optimizing each experimental variable, the optimized conditions for all other parameters were used. ) injected in triplicate with inset calibration graph is shown in Fig. 4 .
Comparison with other analytical methods
Based on a silver(III) complex-sulfuric acid-HBB system, a sensitive CL reaction is proposed, and is successfully applied to analyze HBB. Several analytical methods have been employed for HBB determination [9] [10] [11] [12] [13] [19] [20] [21] 23 in pharmaceutical formulations. The analytical characteristics of these methods with the proposed method are listed in Table 2 . The proposed method has a comparatively lower LOD, high sample throughput and could be applied to the analysis of low concentrations of HBB in biological fluids after applying suitable separation technique. The method has satisfactory linearity, high sensitivity and good precision.
Interference studies
In order to decrease the effects of foreign substances in the analysis, the effect on the CL emission of some pharmaceutical excipients and inorganic ions was examined on the HBB solution of 0.5 mg L -1 . The tolerable concentration ratios for foreign substances with relative error of 5.0% were over 50-fold for Na + , K + , Ca 2+ , Mg 2+ , Zn 2+ , NH4
, NO3 -and Cl -; 10-fold for starch, acacia, tartaric acid, silica, glucose, and sucrose; 5-fold for povidone and polyethylene glycol. The basic excipients of HBB in pharmaceutical form are stearic acid, titan dioxide, starch and lactose had no significant influence on the determination of HBB.
Applications
The concentration of HBB in commercially available pharmaceutical formulations (tablets and ampoules) was determined by the proposed FI-CL method. The % recovery was in the range from 92 ± 4 to 108 ± 3% (Table 3 ). The accuracy of proposed FI-CL technique was validated by comparing the results obtained with a conventional spectrophotometric technique, 9 and results are listed in 
CL mechanism
Fluorescence study of HBB was performed using a spectrofluorometer (RF-1501, Shimadzu, Kyoto, Japan). The HBB has UV-vis absorption at 210 nm 15 thus its excitation wavelength was fixed at 210 nm and the fluorescence emission spectrum was monitored under aqueous sulfuric acid (0.5 mol L -1 ) medium, which gave an intense fluorescence emission curve centered at 469 nm. Silver(III) complex dissociates in aqueous sulfuric acid medium producing super oxide anion radicals, 35, 38 and recombination of super oxide anion radical results in the formation of an excited dimmer of oxygen molecule releasing the energy after de-excitation in the form of light at 490 nm. 44 The energy from the excited dimer of oxygen molecule could be transferred to the HBB molecule through intermolecular 
Conclusions
The proposed FI-CL method is sensitive and rapid for the analysis of HBB and applied successfully to commercially available pharmaceutical formulations. The results obtained were in good agreement with the spectrophotometric method.
The method was reproducible with RSD of 1.5% for 0.5 mg L -1 HBB, sensitive (5 × 10 -4 mg L -1 ) and rapid (160 h -1 ). Further, the possible CL reaction mechanism of silver(III) complexsulfuric acid-HBB is also briefly described.
